# Investigation of Antipsoriatic Effects of UVB-induced Synthesis of 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol)in Keratinocytes of Psoriatic Skin, Using Cytochrom-P(CYP)Inhibitor Ketokonazol

> **NCT00678756** · PHASE2 · UNKNOWN · sponsor: **Technische Universität Dresden** · enrollment: 12 (estimated)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** Ketokonazol 2% cream
- **RADIATION:** UVB-radiation 311nm

## Key facts

- **NCT ID:** NCT00678756
- **Lead sponsor:** Technische Universität Dresden
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-03
- **Primary completion:** 2009-10
- **Final completion:** 2009-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2010-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00678756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00678756, "Investigation of Antipsoriatic Effects of UVB-induced Synthesis of 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol)in Keratinocytes of Psoriatic Skin, Using Cytochrom-P(CYP)Inhibitor Ketokonazol". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00678756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*